Arslan, Salim http://orcid.org/0000-0002-4329-0947
Schmidt, Julian
Bass, Cher http://orcid.org/0000-0002-7928-3394
Mehrotra, Debapriya
Geraldes, Andre
Singhal, Shikha
Hense, Julius
Li, Xiusi
Raharja-Liu, Pandu http://orcid.org/0000-0001-6707-6278
Maiques, Oscar
Kather, Jakob Nikolas http://orcid.org/0000-0002-3730-5348
Pandya, Pahini
Article History
Received: 25 November 2022
Accepted: 29 February 2024
First Online: 15 March 2024
Competing interests
: The authors declare the following competing interests: S.A., D.M., S.S., X.L., J.H., J.S., A.G., C.B., P.P., and P.R.-L. are employees of Panakeia Technologies, UK. J.N.K. declares consulting services for Owkin, France, DoMore Diagnostics, Norway, Panakeia Technologies, UK, Scailyte, Switzerland, Cancilico, Germany, Mindpeak, Germany, MultiplexDx, Slovakia, and Histofy, UK; furthermore he holds shares in StratifAI GmbH, Germany, has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Eisai, Janssen, MSD, BMS, Roche, Pfizer and Fresenius. O.M. receives consulting services for Panakeia Technologies, UK. The authors declare no other competing interests.